Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study

294

Citations

21

References

2013

Year

Michael Mannstadt, B.L. Clarke, Tamara Vokes, Maria Luisa Brandi, L. Ranganath, William D. Fraser, Péter Lakatos, László Bajnok, Roger J. Garceau, Leif Mosekilde,

The Lancet Diabetes & Endocrinology

Parathyroid HormoneParathyroid DiseaseGynecologyThyroid DisordersEndocrinologyMedicineOrthopaedic Surgery

References

	Year	Citations

Page 1